KIA
EW icon

Kopp Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Kopp Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,666
Closed -$234K – 50
2019
Q1 		$234K Buy
+3,666
New +$209K 0.19% 57
2018
Q2 		– Sell
-7,668
Closed -$357K – 62
2018
Q1 		$357K Sell
7,668
-321
-4% -$13.9K 0.36% 54
2017
Q4 		$300K Sell
7,989
-249
-3% -$9.14K 0.3% 55
2017
Q3 		$300K Buy
8,238
+1,842
+29% +$70.3K 0.27% 55
2017
Q2 		$252K Hold
6,396
– – 0.23% 55
2017
Q1 		$201K Sell
6,396
-270
-4% -$8.45K 0.2% 58
2016
Q4 		$208K Buy
+6,666
New +$216K 0.22% 57

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Kopp Investment Advisors's EW Position: Q2 2019 in Review

Kopp Investment Advisors sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 3,666 shares — an estimated $234K sold.

Kopp Investment Advisors first reported a position in EW in Q4 2016 and held it in 7 quarters. The position peaked at $357K in Q1 2018. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Kopp Investment Advisors reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Kopp Investment Advisors sold 3,666 Edwards Lifesciences shares in Q2 2019, an estimated $234K.
  • Kopp Investment Advisors first reported a position in Edwards Lifesciences in Q4 2016 and held it in 7 quarters.
  • Kopp Investment Advisors's Edwards Lifesciences position peaked at $357K in Q1 2018.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Kopp Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.